Optimal protocol of boron neutron captute therapy for malignant melanoma
Not Applicable
Completed
- Conditions
- Malignant melanoma
- Registration Number
- JPRN-UMIN000005124
- Lead Sponsor
- Department of Radiation Oncology, Kawasaki Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
*Having a severe renal disease *Judged as being unsuitable for trial by the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor effect and side effect
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie boron neutron capture therapy for melanoma metastases?
How does boron neutron capture therapy compare to immunotherapy in advanced melanoma treatment?
What biomarkers are used to select patients for boron neutron capture therapy in melanoma?
What are the common adverse events associated with boron neutron capture therapy for melanoma?
Are there combination therapies being explored with boron neutron capture for melanoma treatment?